NCT03803410|Completed
Surveillance of HCV in Uremics and Linking to Medical Care
Comprehensive Surveillance of HCV Infecion in Uremics Under Maintenance Hemodialysis and Linking to Medical Care in Taiwan
Loading search results
Comprehensive Surveillance of HCV Infecion in Uremics Under Maintenance Hemodialysis and Linking to Medical Care in Taiwan
Sponsor study identifier
observational
2,973
1 country
1
Study Start
January 7, 2019
Actual (reported)Primary Completion
May 20, 2022
Actual (reported)Study Completion
May 20, 2022
Actual (reported)HCV remains to prevail in the uremic patients under hemodialysis. The comprehensive surveillance in the risk population facilitates the link to care for HCV eradication.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 20, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 7, 2019
Actual (reported)January 7, 2019
Actual (reported)January 14, 2019
Actual (reported)May 20, 2022
Actual (reported)May 20, 2022
Actual (reported)HCV prevalence
To explore the current prevalence rate of hepatitis C virus (HCV) infection in uremic patients under maintenance hemodialysis in Taiwan
36 months
liver fibrosis in HCV uremic patients
36 months
Number of participants with potential drug-drug interaction with DAA
36 months
Number of participants with hepatic outcome after HCV eradication
36 months
Number of participants with extra-hepatic outcome after HCV eradication
36 months
blood test of HCV serology and virology.noninvasive test including M2BPGi and fibroscan for liver fibrosis
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
The FORMOSA-LIKE group is a collaborative alliance of Hepatology and Nephrology in Taiwan. It contains around 2000 uremic patients with maintenance hemodialysis in 21 hemodialysis units (one medical center, 4 regional core hospitals and 16 regional clinics). The current study plan to launch a universal surveillance of HCV in the cohort.
Kaohsiung Medical University Hospital
Kaohsiung City, 807, Taiwan
Huang CF, Dai CY, Wang CW, Liang PC, Wei YJ, Tsai PC, Jang TY, Hsu PY, Jia-Jung Lee, Niu SW, Huang JC, Yeh ML, Huang CI, Hsieh MY, Lin YH, Chen SC, Chiu YW, Huang JF, Chang JM, Hwang SJ, Chuang WL, Yu ML; FORMOSA-LIKE investigators. Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort study. Clin Kidney J. 2023 Jun 14;16(12):2429-2436. doi: 10.1093/ckj/sfad138. eCollection 2023 Dec.
Wei YJ, Hsu PY, Lee JJ, Niu SW, Huang JC, Hsu CT, Jang TY, Yeh ML, Huang CI, Liang PC, Lin YH, Hsieh MY, Hsieh MH, Chen SC, Dai CY, Lin ZY, Chen SC, Huang JF, Chang JM, Hwang SJ, Chuang WL, Huang CF, Chiu YW, Yu ML. Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group. J Viral Hepat. 2021 May;28(5):719-727. doi: 10.1111/jvh.13477. Epub 2021 Feb 13.
Ming-Lung Yu, MD.,PhD.
Kaohsiung Medical University
2,973 participants (actual enrollment reported by the registry).
First Submitted
January 7, 2019
First Posted
January 14, 2019
Study Start
January 7, 2019
Actual (reported)A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk
Contact the study team to confirm eligibility.
Yu ML, Huang CF, Wei YJ, Lin WY, Lin YH, Hsu PY, Hsu CT, Liu TW, Lee JJ, Niu SW, Huang JC, Hung TS, Yeh ML, Huang CI, Liang PC, Hsieh MY, Chen SC, Huang JF, Chang JM, Chiu YW, Dai CY, Hwang SJ, Chuang WL; FORMOSA-LIKE investigators. Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C). Gut. 2021 Dec;70(12):2349-2358. doi: 10.1136/gutjnl-2020-323277. Epub 2020 Dec 10.
Primary Completion
May 20, 2022
Actual (reported)Study Completion
May 20, 2022
Actual (reported)Last Updated
June 1, 2022
Record last verified: 2022-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: